JASON BARKER: Open Payments
NPI 1952040164 · SUFFOLK, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 28 payments from 17 companies in 2025. Trend: 2023 $1,329 · 2024 $1,369 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $103 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Corcept Therapeutics | 3 | $64 |
| PFIZER INC. | 2 | $55 |
| SHIELD THERAPEUTICS INC | 1 | $48 |
| Novo Nordisk Inc | 2 | $39 |
| SANOFI-AVENTIS U.S. LLC | 1 | $31 |
| Intercept Pharmaceuticals, Inc. | 1 | $25 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
Products named: Korlym, UBRELVY, NURTEC ODT, ACCRUFER, VRAYLAR, AIRSUPRA, TZIELD, FARXIGA.
Industry payments across VA — which companies pay providers there.
